Io Therapeutics' Unattributed Round

Io Therapeutics raised a round of funding on January 03, 2014.

Io Therapeutics was founded to develop and commercialize a series of retinoid and rexinoid compounds originally discovered at Allergan. The company's strategy includes expanding the uses of the compou…

Articles about Io Therapeutics' Unattributed Round: